Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AGM Results

8th May 2025 14:09

RNS Number : 9370H
Uniphar PLC
08 May 2025
 

AGM Results

 

Dublin, London | 8 May 2025

 

Uniphar plc (the Company) is pleased to announce that at its Annual General Meeting held at 11.00 a.m. today, 8 May 2025, each of the resolutions set out in the Notice of Annual General Meeting circulated to shareholders and made available on the Company's website, www.uniphar.ie, were duly passed without amendment.

Details of votes cast are set out below:

 

 

RESOLUTION

For

For %

Against

Against

%

Withheld

1

Financial Statements and Reports

153,243,069

99.17%

1,278,544

0.83%

132,837

2

Final Dividend of

€3.4m

154,654,450

100.00%

0

0.00%

0

3(a)

Re-elect Ger Rabbette

153,894,576

99.51%

759,874

0.49%

0

3(b)

Re-elect Tim Dolphin

153,864,527

99.51%

761,647

0.49%

28,276

3(c)

Re-elect Paul Hogan

154,120,862

99.65%

533,588

0.35%

0

3(d)

Re-elect Sue Webb

153,923,147

99.55%

703,027

0.45%

28,276

3(e)

Re-elect Jim Gaul

146,614,423

94.80%

8,040,027

5.20%

0

3(f)

Re-elect Liz Hoctor

154,548,421

99.93%

106,029

0.07%

0

3(g)

Re-elect Maurice Pratt

151,621,344

98.04%

3,032,306

1.96%

800

3(h)

Re-elect Valerie Sick

154,335,546

99.79%

318,904

0.21%

0

4

Remuneration of Auditors

111,340,592

92.64%

8,849,615

7.36%

34,464,243

5

Authority to allot relevant securities

129,854,034

83.96%

24,800,416

16.04%

0

6

Disapplication of pre- emption rights in

specified circumstances

153,651,591

99.35%

1,002,859

0.65%

0

7

Disapplication of pre- emption rights in additional

circumstances

124,033,872

80.46%

30,127,960

19.54%

492,618

8

Authorise market purchases of the Company's Ordinary Shares

154,058,953

100.00%

0

0.00%

595,497

9

Re-issuance of Treasury Shares

154,654,450

100.00%

0

0.00%

0

 

 

--- ENDS ---

Contact details

Uniphar Group

 

Tel: +353 (0) 1 428 7777

Allan Smylie, Head of Strategy and IR

Davy (Joint Corporate Broker, Nominated Advisor and

Euronext Growth Listing Sponsor)

 

Tel: +353 (0) 1 679 6363

Daragh O'Reilly

Niall Gilchrist

Ivan Murphy

RBC Capital Markets (Joint Corporate Broker)

 

Tel: +44 (0) 20 7653 4000

Jamil Miah

Rupert Walford

Stifel Nicolaus Europe Limited (Joint Corporate Broker)

 

Tel: +44 (0) 20 7710 7600

Matt Blawat

Ben Maddison

Francis North

Q4 PR

 

Tel: +353 (0) 1 475 1444

Iarla Mongey, Public Relations Advisor to Uniphar Group

 

 

About Uniphar plc 

Headquartered in Dublin, Ireland, the Uniphar Group is an international diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Medtech, Uniphar Pharma and Uniphar Supply Chain & Retail. The Group is active in Europe, North America, APAC and MENA and delivers to 160+ countries.

 

Uniphar solves problems for healthcare. We sit in the middle between the manufacturers and their stakeholders, and we help them both to overcome the problems of a new, complicated healthcare environment. The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare professionals and their patients. Uniphar represents a strong combination of scale, growth, and profitability.

 

Uniphar Medtech

Uniphar Medtech is a leading pan-European medical device distributor and solutions partner. The Group's strategy for Uniphar Medtech is to grow our service offering across Europe and expand our addressable market by serving new specialities and new manufacturers.

 

Uniphar Pharma

Uniphar Pharma operates a global business with high value services across the lifecycle of a pharmaceutical product. We enable pharma and biotech companies to bring innovative medicines to global markets and provide healthcare professionals with access to medicines they cannot source through traditional channels. Our strategy is to build a leading platform to provide the specialist support and expertise needed to improve access to these medicines.

 

Uniphar Supply Chain & Retail

Uniphar Supply Chain & Retail is the leading pharmaceutical wholesaler in Ireland with a growing symbol group offering of retail pharmacies. The Group's strategy for Uniphar Supply Chain & Retail is to grow our wholesale market share, our symbol group network and our own brand, in-licenced and consumer products portfolio.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMPKFBKNBKDOPK

Related Shares:

Uniphar
FTSE 100 Latest
Value8,566.13
Change34.52